Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB(1) receptor availability

BACKGROUND: Obesity is a pressing public health concern worldwide. Novel pharmacological means are urgently needed to combat the increase of obesity and accompanying type 2 diabetes (T2D). Although fully established obesity is associated with neuromolecular alterations and insulin resistance in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantonen, Tatu, Pekkarinen, Laura, Karjalainen, Tomi, Bucci, Marco, Kalliokoski, Kari, Haaparanta-Solin, Merja, Aarnio, Richard, Dickens, Alex M., von Eyken, Annie, Laitinen, Kirsi, Houttu, Noora, Kirjavainen, Anna K., Helin, Semi, Hirvonen, Jussi, Rönnemaa, Tapani, Nuutila, Pirjo, Nummenmaa, Lauri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794779/
https://www.ncbi.nlm.nih.gov/pubmed/34728775
http://dx.doi.org/10.1038/s41366-021-00996-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794779/
https://www.ncbi.nlm.nih.gov/pubmed/34728775
http://dx.doi.org/10.1038/s41366-021-00996-y

Ejemplares similares